Systemic therapy for metastatic renal-cell carcinoma
TK Choueiri, RJ Motzer - New England Journal of Medicine, 2017 - Mass Medical Soc
New England Journal of Medicine, 2017•Mass Medical Soc
Kidney cancers have been extensively studied, and insights from an increased
understanding of tumor biology have led to increases in survival rates. Therapies aimed at
tumor signaling pathways and immunotherapies have improved the outlook for patients with
renal cancer.
understanding of tumor biology have led to increases in survival rates. Therapies aimed at
tumor signaling pathways and immunotherapies have improved the outlook for patients with
renal cancer.
Kidney cancers have been extensively studied, and insights from an increased understanding of tumor biology have led to increases in survival rates. Therapies aimed at tumor signaling pathways and immunotherapies have improved the outlook for patients with renal cancer.
The New England Journal Of Medicine